DGAP-PVR: STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with

DGAP-PVR: STRATEC Biomedical AG: Release according to Article 26, Section 1 of 
the WpHG [the German Securities Trading Act] with the objective of Europe-wide 
distribution

STRATEC Biomedical AG 

25.10.2013 17:19

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------


Allianz SE, Munich, Germany, has notified us pursuant to section 21 (1) of
the German Securities Trading Act (WpHG) on October 21, 2013 as follows:

'We hereby give notice pursuant to section 21 (1) of the German Securities
Trading Act (WpHG) that our voting rights in STRATEC Biomedical AG,
Gewerbestr. 37, 75217 Birkenfeld, went above the threshold of 3% on October
17, 2013 and amounted to 3.02% of all voting rights of the company (this
reflects 354,690 of all 11,747,745 voting rights).

These voting rights are attributed to us pursuant to section 22 (1)
sentence 1 number 1 of the German Securities Trading Act (WpHG) and at the
same time pursuant to section 22 (1) sentence 1 number 6 in conjunction
with sentence 2 of the German Securities Trading Act (WpHG).'


At the same time Allianz SE, Munich, Germany, has notified us pursuant to
section 21 (1) in conjunction with section 24 of the German Securities
Trading Act (WpHG) as follows:

1. Allianz Asset Management AG
The share of voting rights held by Allianz Asset Management AG, Munich,
Germany, in STRATEC Biomedical AG, Gewerbestr. 37, 75217 Birkenfeld,
Germany, went above the threshold of 3% on October 17, 2013 and amounted to
3.02% of all voting rights of the company (this reflects 354,690 of all
11,747,745 voting rights). These voting rights are attributed pursuant to
section 22 (1) sentence 1 number 6 in conjunction with sentence 2 of the
German Securities Trading Act (WpHG).

2. Allianz Global Investors GmbH
The share of voting rights held by Allianz Global Investors GmbH, Munich,
Germany, in STRATEC Biomedical AG, Gewerbestr. 37, 75217 Birkenfeld,
Germany, went above the threshold of 3% on October 17, 2013 and amounted to
3.02% of all voting rights of the company (this reflects 354,690 of all
11,747,745 voting rights). These voting rights are attributed pursuant to
section 22 (1) sentence 1 number 6 in conjunction with sentence 2 of the
German Securities Trading Act (WpHG).



25.10.2013 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      STRATEC Biomedical AG
              Gewerbestr. 37
              75217 Birkenfeld
              Germany
Internet:     www.stratec.com
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------
 
Press spacebar to pause and continue. Press esc to stop.